Industry: Healthcare Region: Spain Deal Price: $1 million Deal Method: Equity financing
Brief introduction:
The company wants to provide technical support.
Details:
The Spanish company has developed a solution that uses artificial intelligence to identify symptoms of shortness of breath to help patients who don't feel it.
Shortness of breath is a very common symptom in everyday life, and even more so now. At present, COVID-19 is ravaging the world, and the symptoms of shortness of breath are frequent. When you are sick, you need to measure not only your temperature, but also blood oxygen saturation. 62.4 percent of critically ill patients do not feel the lack of oxygen, which can be detected by artificial intelligence.
If you feel shortness of breath, you can send a voice message and count from 1 to 30 in your native language to see if your symptoms are normal. Mastering their own health, reducing uncertainty and anxiety, with an accuracy rate of 91%.
This tool is not only suitable for the early diagnosis of COVID-19, but also for chronic obstructive pulmonary disease, asthma, etc., and can also be used as an aid to physical exercise.